['alcoholism', 'substance-related disorders']
['intranasal oxytocin spray']

        Inclusion Criteria:

          1. At least one prior episode 2 days or longer in duration during which the subject
             experienced withdrawal symptoms that caused significant incapacitation (e.g.,
             inability to work or do normal activities) OR at least one prior inpatient or
             outpatient medical detoxification during which the subject exhibited withdrawal
             symptoms of sufficient magnitude that sedative-hypnotic or anticonvulsant medication
             was required at least once on 2 consecutive days after cessation of or reduction in
             the use of alcohol following 2 weeks or more of heavy daily consumption

          2. average consumption of 8-30 standard drinks per day for at least 2 weeks prior to
             enrollment in the study;

          3. consenting to participate in the study;

          4. have residency in Trøndelag County after discharge

        Exclusion Criteria:

          1. chronic treatment with sedative-hypnotic medications such as benzodiazepines or
             z-hypnotics;

          2. dependence on substances other than alcohol, nicotine or caffeine;

          3. inadequately treated, unstable and/or compromising medical or psychiatric conditions;

          4. low body weight (BMI < 17) or history of anorexia nervosa or bulimia in the past 2
             years;

          5. pregnancy; parturition or breast-feeding in the past 6 months;

          6. inability to read well enough to complete study questionnaires determined by whether
             the prospective subject can read the consent form without help and correctly answer
             basic questions about information in the consent form;

          7. no alcohol in the blood and > 15 h since last intake of alcohol;

          8. prior inclusion and participation in the same study.
      